Sponsor:
Pelage Pharmaceuticals, Inc.
Code:
NCT07907783
Conditions
Androgenetic Alopecia
Eligibility Criteria
Sex: Female
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
PP405 0.05% Topical Gel
Vehicle Topical Gel
Brief summary:
Conditions
Androgenetic Alopecia
Study ID
NCT07907783
Start date
Nov 10, 2026
Status verified date
Nov, 2026
Completion date
Mar, 2028
Anticipated
Primary completion date
Sep, 2027
Anticipated
Eligibility Criteria
Sex: Female
Age: 18 - 65
Healthy Volunteers: Not accepted
Enrollment
200 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: PP405 0.05% Topical Gel
placebo comparator: Vehicle Topical Gel
Interventions
PP405 0.05% Topical Gel
Vehicle Topical Gel
Primary outcome measure
Central contacts
Locations
Burke Pharmaceutical Research
Recruiting
Hot Springs, Arkansas, United States, 71913
DelRicht Research (Experience Dermatology)
Recruiting
Atlanta, Georgia, United States, 30329
Equity Medical, LLC
Recruiting
New York, New York, United States, 10023
DelRicht @Mt Pleasant Dermatology
Recruiting
Mt. Pleasant, South Carolina, United States, 29464
DelRicht Research @Harpeth Valley Dermatology
Recruiting
Smyrna, Tennessee, United States, 37167
Institution: Delricht Research @Lockhart
Recruiting
Prosper, Texas, United States, 75078
Sponsor
Pelage Pharmaceuticals, Inc.
Last update posted
Nov 17, 2026
Last verified
Nov, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-18. This information was provided to ClinicalTrials.gov by Pelage Pharmaceuticals, Inc. on 2026-11-17. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.